tiprankstipranks
Advertisement
Advertisement
Winrevair’s Mixed Phase 2 Signal Leaves Merck’s Risk‑Reward Balanced, Supporting a Hold Rating
PremiumRatingsWinrevair’s Mixed Phase 2 Signal Leaves Merck’s Risk‑Reward Balanced, Supporting a Hold Rating
2d ago
Merck announces data from Phase 2 Cadence trial of Winrevair
Premium
The Fly
Merck announces data from Phase 2 Cadence trial of Winrevair
2d ago
Wix downgraded, TripAdvisor upgraded: Wall Street’s top analyst calls
Premium
The Fly
Wix downgraded, TripAdvisor upgraded: Wall Street’s top analyst calls
5d ago
Midday Fly By: Merck to acquire Terns, Arm CPU launch applauded
PremiumThe FlyMidday Fly By: Merck to acquire Terns, Arm CPU launch applauded
6d ago
Merck’s offer for Terns leaves room for another bidder, says William Blair
Premium
The Fly
Merck’s offer for Terns leaves room for another bidder, says William Blair
6d ago
Merck’s offer for Terns leaves room for another bidder, says William Blair
Premium
The Fly
Merck’s offer for Terns leaves room for another bidder, says William Blair
7d ago
Video: Arm jumps as analysts react favorably to business model shift, guidance
PremiumThe FlyVideo: Arm jumps as analysts react favorably to business model shift, guidance
7d ago
Merck Snaps Up Terns Pharma in $5.7B Deal Ahead of Keytruda Patent Expiry — TERN and MRK Stocks Rise
Premium
Market News
Merck Snaps Up Terns Pharma in $5.7B Deal Ahead of Keytruda Patent Expiry — TERN and MRK Stocks Rise
7d ago
Enliven up 20% after Terns Pharmaceuticals agrees to be bought by Merck
Premium
The Fly
Enliven up 20% after Terns Pharmaceuticals agrees to be bought by Merck
7d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100